Global Embolotherapy Market is Set to Reach USD 3.6 billion by 2022, Observing a CAGR of 6.8% during 2023–2030
The global embolotherapy market is expected to grow at a CAGR of 6.8% during the forecast period with its market size predicted was at USD 3.6 billion by 2030. Globally, embolotherapy industry players are undertaking considerable investment decisions and launching new products in order gain competitive advantage. Moreover, entering into partnership agreements and performing mergers & acquisitions are the key development strategies being implemented by the crucial players in global embolotherapy market.
Hospital and clinics category held largest share in the embolotherapy market in 2022
Based on end user, the global embolotherapy market is segmented into ambulatory surgical centers (ASCs), hospitals and clinics, and others. Amongst these segments, hospitals and clinics are dominating in terms of revenue throughout the estimated period owing to extensive accessibility of reimbursements policies being implemented by hospitals and clinics and excessive adoption of these devices in small clinics, big hospitals and critical care units.
Browse Market Insight and In-depth TOC on "Global Embolotherapy Market - Analysis and Forecast (2023-2030)"
Geography Insight
North America has accounted for the largest share in embolotherapy market, globally and is predicted to grow significantly during the forecast period, owing to the increasing emphasis in the region towards development of advanced embolic agents, extensive pervasiveness of incidents that necessitates adoption of embolization processes. Moreover, established healthcare system in this region is the key factor that is further anticipated to drive the growth of embolotherapy market in this region.
Competitive Insight
Some of the players having prominent presence in the global embolotherapy market include Merit Medical Systems, Acandis GmbH, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Terumo Corporation, Stryker Corporation, Johnson & Johnson, BALT Extrusion, Sirtex Medical Limited, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Penumbra, Inc., and BTG Plc.
Key Takeaway from the Report:
- Among all the product, embolic agents segment held the larger share in the market in 2022.
- Of all the procedure, TAE segment is anticipated to generate largest revenue throughout the estimated period.
- Among all the indication, cancer category held the largest share in the market in 2022.
- Among all the end users, the hospitals and clinics category held the largest share in the embolotherapy market in 2022.
The Report Offers:
- Historical market estimate for the years 2018–2022 and forecast for the years 2023–2030
- Insight on current market trends, market dynamics, key opportunities and major challenges in the industry
- Market insights by in-depth segmentation with industry dynamics.
- Competitive analysis and benchmarking of the industry leaders and their product offerings
- Profiles of leading players and innovators, their financial overview and product portfolio
- Analysis of key industry trends and recent developments
- Value chain analysis and distribution channel analysis with opportunity assessment
- Market share analysis of major players
Benefits of Report Purchase from VynZ:
Detailed Research
We provide accurate data and in-depth analysis with all-inclusive coverage.
Robust Research Methodology
Robust research methodology and data triangulation to ensure high quality report.
Analyst Support
24*7 analyst support – Pre and post purchase of the report as well as during the project tenure.
Sales Support
24*7 sales support – Hassle free delivery of the report and quick response and support by sales team.
Free Customization
20% post purchase free customization to meet your requirements.
Customer Satisfaction
We claim full customer satisfaction as our core values lie in building long term relationship.
Security
High level of data security and confidentiality of your information.
The report provides the market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue (USD Million) and Volume (Unit). The report segments the global embolotherapy market on the basis of product, procedure, indication, end user, and region.
Global Embolotherapy Market Coverage
Product Insight and Forecast 2018-2030
- Embolic Agents
- Microspheres
- Embolic Coils
- Liquid Embolic Agents
- Embolic Plug Systems
- Detachable Balloons
- Support Devices
- Microcatheters
- Guidewires
Procedure Insight and Forecast 2018-2030
- Transcatheter Arterial Embolization (TAE)
- Transarterial Chemoembolization (TACE)
- Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
Indication Insight and Forecast 2018-2030
- Cancer
- Liver
- Kidney
- Others
- Neurological Diseases
- Cerebral Aneurysm
- Arteriovenous Malformation And Fistulas
- Peripheral Vascular Diseases
- Urological and Nephrological Disorders
- Gastrointestinal Disorders
End User Insight and Forecast 2018-2030
- Hospitals and Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
Geographical Segmentation
Embolotherapy Market by Region
North America
- By Product
- By Procedure
- By Indication
- By End User
- By Country – U.S., Canada, and Mexico
- U.S. Market
- By Product
- By Procedure
- By Indication
- By End User
- Canada Market
- By Product
- By Procedure
- By Indication
- By End User
- Mexico Market
- By Product
- By Procedure
- By Indication
- By End User
- U.S. Market
Europe
- By Product
- By Procedure
- By Indication
- By End User
- By Country – Germany, U.K., France, Italy, Spain, and Rest of Europe
- Germany Market
- By Product
- By Procedure
- By Indication
- By End User
- U.K. Market
- By Product
- By Procedure
- By Indication
- By End User
- France Market
- By Product
- By Procedure
- By Indication
- By End User
- Italy Market
- By Product
- By Procedure
- By Indication
- By End User
- Spain Market
- By Product
- By Procedure
- By Indication
- By End User
- Rest of Europe Market
- By Product
- By Procedure
- By Indication
- By End User
- Germany Market
Asia-Pacific (APAC)
- By Product
- By Procedure
- By Indication
- By End User
- By Country – China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific
- China Market
- By Product
- By Procedure
- By Indication
- By End User
- Japan Market
- By Product
- By Procedure
- By Indication
- By End User
- India Market
- By Product
- By Procedure
- By Indication
- By End User
- South Korea Market
- By Product
- By Procedure
- By Indication
- By End User
- Singapore Market
- By Product
- By Procedure
- By Indication
- By End User
- Rest of Asia-Pacific Market
- By Product
- By Procedure
- By Indication
- By End User
- China Market
Rest of the World (RoW)
- By Product
- By Procedure
- By Indication
- By End User
- By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries
- Brazil Market
- By Product
- By Procedure
- By Indication
- By End User
- Saudi Arabia Market
- By Product
- By Procedure
- By Indication
- By End User
- South Africa Market
- By Product
- By Procedure
- By Indication
- By End User
- Other Countries Market
- By Product
- By Procedure
- By Indication
- By End User
- Brazil Market